购物车
- 全部删除
- 您的购物车当前为空
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) 是一种选择性 S1P2拮抗剂,可用于特发性肺纤维化的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) 是一种选择性 S1P2拮抗剂,可用于特发性肺纤维化的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 598 | 现货 | |
5 mg | ¥ 1,620 | 现货 | |
10 mg | ¥ 2,860 | 现货 | |
25 mg | ¥ 4,750 | 现货 | |
50 mg | ¥ 6,780 | 现货 | |
100 mg | ¥ 9,190 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,790 | 现货 |
产品描述 | GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and selective antagonist of S1P2. |
体外活性 | GLPG2938在所有测试浓度下显著阻止了S1P介导的收缩[1]。 |
体内活性 | 在所有物种中,GLPG2938显示出良好的药代动力学特性,具有长半衰期、低清除率和良好的生物利用度。 |
别名 | 1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea |
分子量 | 503.4 |
分子式 | C20H19F6N7O2 |
CAS No. | 2130996-00-6 |
Smiles | CCOc1cc(NC(=O)NCc2cc(C)c(nn2)-c2cn(C)nc2C(F)(F)F)cc(n1)C(F)(F)F |
密度 | 1.49 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/ml (119.19 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容